179 related articles for article (PubMed ID: 26930753)
1. Oral Cancer Chernoprevention: Current Status and Future Direction.
Messadi DV; Sato K
J Calif Dent Assoc; 2016 Feb; 44(2):101-11. PubMed ID: 26930753
[TBL] [Abstract][Full Text] [Related]
2. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
[TBL] [Abstract][Full Text] [Related]
3. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.
Meyskens FL
Ann N Y Acad Sci; 2001 Dec; 952():116-23. PubMed ID: 11795430
[TBL] [Abstract][Full Text] [Related]
4. Chronicles in drug discovery.
Moral MA; Khurdayan VK; Bozzo J
Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
[TBL] [Abstract][Full Text] [Related]
5. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
Armstrong WB; Kennedy AR; Wan XS; Atiba J; McLaren CE; Meyskens FL
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):43-7. PubMed ID: 10667462
[TBL] [Abstract][Full Text] [Related]
6. Optimizing biomarkers and endpoints in oral cancer chemoprevention trials.
William WN; Papadimitrakopoulou VA
Cancer Prev Res (Phila); 2013 May; 6(5):375-8. PubMed ID: 23639861
[TBL] [Abstract][Full Text] [Related]
7. Development of difluoromethyl-ornithine and Bowman-Birk inhibitor as chemopreventive agents by assessment of relevant biomarker modulation: some lessons learned.
Meyskens FL
IARC Sci Publ; 2001; 154():49-55. PubMed ID: 11220668
[TBL] [Abstract][Full Text] [Related]
8. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
Armstrong WB; Kennedy AR; Wan XS; Taylor TH; Nguyen QA; Jensen J; Thompson W; Lagerberg W; Meyskens FL
Clin Cancer Res; 2000 Dec; 6(12):4684-91. PubMed ID: 11156220
[TBL] [Abstract][Full Text] [Related]
9. Oral cancer prevention: the case for carotenoids and anti-oxidant nutrients.
Garewal H; Meyskens F; Friedman S; Alberts D; Ramsey L
Prev Med; 1993 Sep; 22(5):701-11. PubMed ID: 8234210
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma and precursor lesions: prevention.
Warnakulasuriya S
Periodontol 2000; 2011 Oct; 57(1):38-50. PubMed ID: 21781178
[No Abstract] [Full Text] [Related]
11. Oral Cancer: Novel Concepts for the Oral Health Care Practitioner.
Messadi DV
J Calif Dent Assoc; 2016 Feb; 44(2):82-4. PubMed ID: 26930750
[No Abstract] [Full Text] [Related]
12. Retinoids: application in premalignant lesions and oral cancer.
Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF
Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628
[TBL] [Abstract][Full Text] [Related]
13. Biology of oral premalignant lesions: concepts and implications for chemoprevention.
Papadimitrakopoulou VA; Hong WK
Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():87-93. PubMed ID: 9061300
[No Abstract] [Full Text] [Related]
14. Potential role of beta-carotene and antioxidant vitamins in the prevention of oral cancer.
Garewal HS
Ann N Y Acad Sci; 1992 Sep; 669():260-7; discussion 267-8. PubMed ID: 1444031
[No Abstract] [Full Text] [Related]
15. Protease inhibitors in oral carcinogenesis and chemoprevention.
Lippman SM; Matrisian LM
Clin Cancer Res; 2000 Dec; 6(12):4599-603. PubMed ID: 11156207
[No Abstract] [Full Text] [Related]
16. Chemoprevention of head and neck cancer.
Gustin DM
Semin Oncol; 2004 Dec; 31(6):769-77. PubMed ID: 15599854
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin.
Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A
Cancer Res; 1995 Sep; 55(18):4059-64. PubMed ID: 7664280
[TBL] [Abstract][Full Text] [Related]
18. Lycopene: features and potential significance in the oral cancer and precancerous lesions.
Lu R; Dan H; Wu R; Meng W; Liu N; Jin X; Zhou M; Zeng X; Zhou G; Chen Q
J Oral Pathol Med; 2011 May; 40(5):361-8. PubMed ID: 21198870
[TBL] [Abstract][Full Text] [Related]
19. Black tea (Camellia sinensis) as a chemopreventive agent in oral precancerous lesions.
Halder A; Raychowdhury R; Ghosh A; De M
J Environ Pathol Toxicol Oncol; 2005; 24(2):141-4. PubMed ID: 15831086
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention.
Monteiro de Oliveira Novaes JA; William WN
Future Oncol; 2016 Oct; 12(20):2379-86. PubMed ID: 27329013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
